CTI BioPharma


CTI BioPharma (NASDAQ: CTIC) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers.

Employees

201-500

Links


Org chart

Adam R. Craig
President, CEO & Interim Chief Medical Officer
Collapse
James K. Fong
SVP, Commercial Operations
Mary Beth Lanza
Senior Director Learning And Development
Wendy Wilson
Associate Director Medical Affairs
Allison Hylton
Senior Corporate Controller/senior Director

Board & advisors



Offices